nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—CYP3A4—Pimecrolimus—atopic dermatitis	0.135	0.258	CbGbCtD
Fulvestrant—CYP3A4—Tacrolimus—atopic dermatitis	0.0804	0.153	CbGbCtD
Fulvestrant—CYP3A4—Loratadine—atopic dermatitis	0.0589	0.112	CbGbCtD
Fulvestrant—CYP3A4—Methylprednisolone—atopic dermatitis	0.0538	0.103	CbGbCtD
Fulvestrant—CYP3A4—Triamcinolone—atopic dermatitis	0.0408	0.0778	CbGbCtD
Fulvestrant—CYP3A4—Betamethasone—atopic dermatitis	0.035	0.0667	CbGbCtD
Fulvestrant—CYP3A4—Prednisolone—atopic dermatitis	0.0345	0.0659	CbGbCtD
Fulvestrant—CYP3A4—Hydrocortisone—atopic dermatitis	0.0327	0.0624	CbGbCtD
Fulvestrant—CYP3A4—Prednisone—atopic dermatitis	0.0326	0.0622	CbGbCtD
Fulvestrant—CYP3A4—Dexamethasone—atopic dermatitis	0.0204	0.0388	CbGbCtD
Fulvestrant—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000757	0.00161	CcSEcCtD
Fulvestrant—Sweating—Methylprednisolone—atopic dermatitis	0.000756	0.0016	CcSEcCtD
Fulvestrant—Dyspepsia—Tacrolimus—atopic dermatitis	0.000755	0.0016	CcSEcCtD
Fulvestrant—Haemorrhage—Hydrocortisone—atopic dermatitis	0.000753	0.0016	CcSEcCtD
Fulvestrant—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000746	0.00158	CcSEcCtD
Fulvestrant—Nausea—Loratadine—atopic dermatitis	0.000746	0.00158	CcSEcCtD
Fulvestrant—Decreased appetite—Tacrolimus—atopic dermatitis	0.000746	0.00158	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000741	0.00157	CcSEcCtD
Fulvestrant—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.00074	0.00157	CcSEcCtD
Fulvestrant—Fatigue—Tacrolimus—atopic dermatitis	0.00074	0.00157	CcSEcCtD
Fulvestrant—Diarrhoea—Mometasone—atopic dermatitis	0.000737	0.00156	CcSEcCtD
Fulvestrant—Pain—Tacrolimus—atopic dermatitis	0.000734	0.00156	CcSEcCtD
Fulvestrant—Constipation—Tacrolimus—atopic dermatitis	0.000734	0.00156	CcSEcCtD
Fulvestrant—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000718	0.00152	CcSEcCtD
Fulvestrant—Haemoglobin—Triamcinolone—atopic dermatitis	0.000713	0.00151	CcSEcCtD
Fulvestrant—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000712	0.00151	CcSEcCtD
Fulvestrant—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000711	0.00151	CcSEcCtD
Fulvestrant—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000711	0.00151	CcSEcCtD
Fulvestrant—Haemorrhage—Triamcinolone—atopic dermatitis	0.000709	0.0015	CcSEcCtD
Fulvestrant—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000708	0.0015	CcSEcCtD
Fulvestrant—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000707	0.0015	CcSEcCtD
Fulvestrant—Pharyngitis—Triamcinolone—atopic dermatitis	0.000704	0.00149	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000701	0.00149	CcSEcCtD
Fulvestrant—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000695	0.00148	CcSEcCtD
Fulvestrant—Vomiting—Mometasone—atopic dermatitis	0.000685	0.00145	CcSEcCtD
Fulvestrant—Urticaria—Tacrolimus—atopic dermatitis	0.000681	0.00145	CcSEcCtD
Fulvestrant—Immune system disorder—Hydrocortisone—atopic dermatitis	0.00068	0.00144	CcSEcCtD
Fulvestrant—Rash—Mometasone—atopic dermatitis	0.00068	0.00144	CcSEcCtD
Fulvestrant—Dermatitis—Mometasone—atopic dermatitis	0.000679	0.00144	CcSEcCtD
Fulvestrant—Abdominal pain—Tacrolimus—atopic dermatitis	0.000678	0.00144	CcSEcCtD
Fulvestrant—Body temperature increased—Tacrolimus—atopic dermatitis	0.000678	0.00144	CcSEcCtD
Fulvestrant—Headache—Mometasone—atopic dermatitis	0.000675	0.00143	CcSEcCtD
Fulvestrant—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00067	0.00142	CcSEcCtD
Fulvestrant—Malnutrition—Hydrocortisone—atopic dermatitis	0.000656	0.00139	CcSEcCtD
Fulvestrant—Haemoglobin—Betamethasone—atopic dermatitis	0.000647	0.00137	CcSEcCtD
Fulvestrant—Haemoglobin—Dexamethasone—atopic dermatitis	0.000647	0.00137	CcSEcCtD
Fulvestrant—Haemorrhage—Betamethasone—atopic dermatitis	0.000643	0.00137	CcSEcCtD
Fulvestrant—Haemorrhage—Dexamethasone—atopic dermatitis	0.000643	0.00137	CcSEcCtD
Fulvestrant—Angiopathy—Methylprednisolone—atopic dermatitis	0.000642	0.00136	CcSEcCtD
Fulvestrant—Nausea—Mometasone—atopic dermatitis	0.00064	0.00136	CcSEcCtD
Fulvestrant—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000639	0.00136	CcSEcCtD
Fulvestrant—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000632	0.00134	CcSEcCtD
Fulvestrant—Depression—Prednisone—atopic dermatitis	0.000622	0.00132	CcSEcCtD
Fulvestrant—Malnutrition—Methylprednisolone—atopic dermatitis	0.000616	0.00131	CcSEcCtD
Fulvestrant—Asthenia—Tacrolimus—atopic dermatitis	0.000615	0.00131	CcSEcCtD
Fulvestrant—Angioedema—Prednisolone—atopic dermatitis	0.000613	0.0013	CcSEcCtD
Fulvestrant—Pruritus—Tacrolimus—atopic dermatitis	0.000607	0.00129	CcSEcCtD
Fulvestrant—Vertigo—Prednisolone—atopic dermatitis	0.000603	0.00128	CcSEcCtD
Fulvestrant—Angioedema—Hydrocortisone—atopic dermatitis	0.000599	0.00127	CcSEcCtD
Fulvestrant—Back pain—Triamcinolone—atopic dermatitis	0.000597	0.00127	CcSEcCtD
Fulvestrant—Vertigo—Hydrocortisone—atopic dermatitis	0.000589	0.00125	CcSEcCtD
Fulvestrant—Diarrhoea—Tacrolimus—atopic dermatitis	0.000587	0.00125	CcSEcCtD
Fulvestrant—Angiopathy—Dexamethasone—atopic dermatitis	0.000584	0.00124	CcSEcCtD
Fulvestrant—Angiopathy—Betamethasone—atopic dermatitis	0.000584	0.00124	CcSEcCtD
Fulvestrant—Dizziness—Tacrolimus—atopic dermatitis	0.000567	0.0012	CcSEcCtD
Fulvestrant—Angioedema—Triamcinolone—atopic dermatitis	0.000564	0.0012	CcSEcCtD
Fulvestrant—Haemoglobin—Prednisone—atopic dermatitis	0.000563	0.00119	CcSEcCtD
Fulvestrant—Angioedema—Methylprednisolone—atopic dermatitis	0.000563	0.00119	CcSEcCtD
Fulvestrant—Haemorrhage—Prednisone—atopic dermatitis	0.00056	0.00119	CcSEcCtD
Fulvestrant—Myalgia—Hydrocortisone—atopic dermatitis	0.000558	0.00118	CcSEcCtD
Fulvestrant—Anxiety—Hydrocortisone—atopic dermatitis	0.000556	0.00118	CcSEcCtD
Fulvestrant—Vertigo—Triamcinolone—atopic dermatitis	0.000555	0.00118	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000554	0.00118	CcSEcCtD
Fulvestrant—Vertigo—Methylprednisolone—atopic dermatitis	0.000553	0.00117	CcSEcCtD
Fulvestrant—Connective tissue disorder—Prednisone—atopic dermatitis	0.000551	0.00117	CcSEcCtD
Fulvestrant—Vomiting—Tacrolimus—atopic dermatitis	0.000545	0.00116	CcSEcCtD
Fulvestrant—Rash—Tacrolimus—atopic dermatitis	0.000541	0.00115	CcSEcCtD
Fulvestrant—Dermatitis—Tacrolimus—atopic dermatitis	0.00054	0.00115	CcSEcCtD
Fulvestrant—Cough—Triamcinolone—atopic dermatitis	0.000539	0.00114	CcSEcCtD
Fulvestrant—Headache—Tacrolimus—atopic dermatitis	0.000537	0.00114	CcSEcCtD
Fulvestrant—Infection—Hydrocortisone—atopic dermatitis	0.000532	0.00113	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisolone—atopic dermatitis	0.00053	0.00112	CcSEcCtD
Fulvestrant—Myalgia—Triamcinolone—atopic dermatitis	0.000526	0.00112	CcSEcCtD
Fulvestrant—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000525	0.00111	CcSEcCtD
Fulvestrant—Myalgia—Methylprednisolone—atopic dermatitis	0.000524	0.00111	CcSEcCtD
Fulvestrant—Arthralgia—Methylprednisolone—atopic dermatitis	0.000524	0.00111	CcSEcCtD
Fulvestrant—Anxiety—Methylprednisolone—atopic dermatitis	0.000523	0.00111	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000521	0.0011	CcSEcCtD
Fulvestrant—Skin disorder—Hydrocortisone—atopic dermatitis	0.00052	0.0011	CcSEcCtD
Fulvestrant—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000517	0.0011	CcSEcCtD
Fulvestrant—Angioedema—Dexamethasone—atopic dermatitis	0.000512	0.00109	CcSEcCtD
Fulvestrant—Angioedema—Betamethasone—atopic dermatitis	0.000512	0.00109	CcSEcCtD
Fulvestrant—Anorexia—Hydrocortisone—atopic dermatitis	0.00051	0.00108	CcSEcCtD
Fulvestrant—Nausea—Tacrolimus—atopic dermatitis	0.00051	0.00108	CcSEcCtD
Fulvestrant—Angiopathy—Prednisone—atopic dermatitis	0.000508	0.00108	CcSEcCtD
Fulvestrant—Immune system disorder—Prednisone—atopic dermatitis	0.000506	0.00107	CcSEcCtD
Fulvestrant—Vertigo—Dexamethasone—atopic dermatitis	0.000503	0.00107	CcSEcCtD
Fulvestrant—Vertigo—Betamethasone—atopic dermatitis	0.000503	0.00107	CcSEcCtD
Fulvestrant—Infection—Triamcinolone—atopic dermatitis	0.000501	0.00106	CcSEcCtD
Fulvestrant—Infection—Methylprednisolone—atopic dermatitis	0.000499	0.00106	CcSEcCtD
Fulvestrant—Insomnia—Prednisolone—atopic dermatitis	0.000496	0.00105	CcSEcCtD
Fulvestrant—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000493	0.00105	CcSEcCtD
Fulvestrant—Paraesthesia—Prednisolone—atopic dermatitis	0.000492	0.00104	CcSEcCtD
Fulvestrant—Skin disorder—Methylprednisolone—atopic dermatitis	0.000488	0.00104	CcSEcCtD
Fulvestrant—Malnutrition—Prednisone—atopic dermatitis	0.000488	0.00103	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000488	0.00103	CcSEcCtD
Fulvestrant—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000487	0.00103	CcSEcCtD
Fulvestrant—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000486	0.00103	CcSEcCtD
Fulvestrant—Insomnia—Hydrocortisone—atopic dermatitis	0.000484	0.00103	CcSEcCtD
Fulvestrant—Paraesthesia—Hydrocortisone—atopic dermatitis	0.00048	0.00102	CcSEcCtD
Fulvestrant—Myalgia—Dexamethasone—atopic dermatitis	0.000477	0.00101	CcSEcCtD
Fulvestrant—Myalgia—Betamethasone—atopic dermatitis	0.000477	0.00101	CcSEcCtD
Fulvestrant—Anxiety—Dexamethasone—atopic dermatitis	0.000475	0.00101	CcSEcCtD
Fulvestrant—Anxiety—Betamethasone—atopic dermatitis	0.000475	0.00101	CcSEcCtD
Fulvestrant—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000471	0.000999	CcSEcCtD
Fulvestrant—Pain—Prednisolone—atopic dermatitis	0.000469	0.000994	CcSEcCtD
Fulvestrant—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000465	0.000987	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000462	0.00098	CcSEcCtD
Fulvestrant—Fatigue—Hydrocortisone—atopic dermatitis	0.000461	0.000979	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000459	0.000974	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000458	0.000972	CcSEcCtD
Fulvestrant—Pain—Hydrocortisone—atopic dermatitis	0.000458	0.000971	CcSEcCtD
Fulvestrant—Insomnia—Triamcinolone—atopic dermatitis	0.000456	0.000967	CcSEcCtD
Fulvestrant—Insomnia—Methylprednisolone—atopic dermatitis	0.000455	0.000965	CcSEcCtD
Fulvestrant—Infection—Dexamethasone—atopic dermatitis	0.000454	0.000964	CcSEcCtD
Fulvestrant—Infection—Betamethasone—atopic dermatitis	0.000454	0.000964	CcSEcCtD
Fulvestrant—Paraesthesia—Triamcinolone—atopic dermatitis	0.000452	0.00096	CcSEcCtD
Fulvestrant—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000451	0.000958	CcSEcCtD
Fulvestrant—Anaemia—Prednisone—atopic dermatitis	0.000451	0.000957	CcSEcCtD
Fulvestrant—Dyspnoea—Triamcinolone—atopic dermatitis	0.000449	0.000953	CcSEcCtD
Fulvestrant—Nervous system disorder—Betamethasone—atopic dermatitis	0.000448	0.000951	CcSEcCtD
Fulvestrant—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000448	0.000951	CcSEcCtD
Fulvestrant—Angioedema—Prednisone—atopic dermatitis	0.000446	0.000946	CcSEcCtD
Fulvestrant—Dyspepsia—Triamcinolone—atopic dermatitis	0.000444	0.000941	CcSEcCtD
Fulvestrant—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000443	0.000939	CcSEcCtD
Fulvestrant—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000442	0.000938	CcSEcCtD
Fulvestrant—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000442	0.000938	CcSEcCtD
Fulvestrant—Vertigo—Prednisone—atopic dermatitis	0.000438	0.00093	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000438	0.000928	CcSEcCtD
Fulvestrant—Anorexia—Dexamethasone—atopic dermatitis	0.000436	0.000925	CcSEcCtD
Fulvestrant—Anorexia—Betamethasone—atopic dermatitis	0.000436	0.000925	CcSEcCtD
Fulvestrant—Urticaria—Prednisolone—atopic dermatitis	0.000435	0.000923	CcSEcCtD
Fulvestrant—Fatigue—Triamcinolone—atopic dermatitis	0.000434	0.000922	CcSEcCtD
Fulvestrant—Fatigue—Methylprednisolone—atopic dermatitis	0.000433	0.00092	CcSEcCtD
Fulvestrant—Pain—Triamcinolone—atopic dermatitis	0.000431	0.000914	CcSEcCtD
Fulvestrant—Urticaria—Hydrocortisone—atopic dermatitis	0.000425	0.000902	CcSEcCtD
Fulvestrant—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000423	0.000897	CcSEcCtD
Fulvestrant—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000423	0.000897	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000417	0.000884	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000417	0.000884	CcSEcCtD
Fulvestrant—Arthralgia—Prednisone—atopic dermatitis	0.000415	0.000881	CcSEcCtD
Fulvestrant—Myalgia—Prednisone—atopic dermatitis	0.000415	0.000881	CcSEcCtD
Fulvestrant—Anxiety—Prednisone—atopic dermatitis	0.000414	0.000878	CcSEcCtD
Fulvestrant—Insomnia—Betamethasone—atopic dermatitis	0.000413	0.000877	CcSEcCtD
Fulvestrant—Insomnia—Dexamethasone—atopic dermatitis	0.000413	0.000877	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000412	0.000875	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000411	0.000872	CcSEcCtD
Fulvestrant—Paraesthesia—Betamethasone—atopic dermatitis	0.000411	0.000871	CcSEcCtD
Fulvestrant—Paraesthesia—Dexamethasone—atopic dermatitis	0.000411	0.000871	CcSEcCtD
Fulvestrant—Hypersensitivity—Prednisolone—atopic dermatitis	0.000404	0.000856	CcSEcCtD
Fulvestrant—Dyspepsia—Betamethasone—atopic dermatitis	0.000402	0.000854	CcSEcCtD
Fulvestrant—Dyspepsia—Dexamethasone—atopic dermatitis	0.000402	0.000854	CcSEcCtD
Fulvestrant—Urticaria—Triamcinolone—atopic dermatitis	0.0004	0.000849	CcSEcCtD
Fulvestrant—Urticaria—Methylprednisolone—atopic dermatitis	0.000399	0.000847	CcSEcCtD
Fulvestrant—Body temperature increased—Triamcinolone—atopic dermatitis	0.000398	0.000845	CcSEcCtD
Fulvestrant—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000397	0.000843	CcSEcCtD
Fulvestrant—Decreased appetite—Dexamethasone—atopic dermatitis	0.000397	0.000843	CcSEcCtD
Fulvestrant—Decreased appetite—Betamethasone—atopic dermatitis	0.000397	0.000843	CcSEcCtD
Fulvestrant—Infection—Prednisone—atopic dermatitis	0.000396	0.000839	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000395	0.000837	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000395	0.000837	CcSEcCtD
Fulvestrant—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000394	0.000836	CcSEcCtD
Fulvestrant—Fatigue—Betamethasone—atopic dermatitis	0.000394	0.000836	CcSEcCtD
Fulvestrant—Fatigue—Dexamethasone—atopic dermatitis	0.000394	0.000836	CcSEcCtD
Fulvestrant—Pain—Betamethasone—atopic dermatitis	0.000391	0.000829	CcSEcCtD
Fulvestrant—Pain—Dexamethasone—atopic dermatitis	0.000391	0.000829	CcSEcCtD
Fulvestrant—Nervous system disorder—Prednisone—atopic dermatitis	0.00039	0.000828	CcSEcCtD
Fulvestrant—Skin disorder—Prednisone—atopic dermatitis	0.000387	0.00082	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisone—atopic dermatitis	0.000385	0.000817	CcSEcCtD
Fulvestrant—Asthenia—Hydrocortisone—atopic dermatitis	0.000384	0.000815	CcSEcCtD
Fulvestrant—Anorexia—Prednisone—atopic dermatitis	0.00038	0.000805	CcSEcCtD
Fulvestrant—Pruritus—Hydrocortisone—atopic dermatitis	0.000379	0.000803	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000374	0.000793	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000374	0.000793	CcSEcCtD
Fulvestrant—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000371	0.000788	CcSEcCtD
Fulvestrant—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.00037	0.000786	CcSEcCtD
Fulvestrant—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000366	0.000777	CcSEcCtD
Fulvestrant—Urticaria—Dexamethasone—atopic dermatitis	0.000363	0.000771	CcSEcCtD
Fulvestrant—Urticaria—Betamethasone—atopic dermatitis	0.000363	0.000771	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000363	0.00077	CcSEcCtD
Fulvestrant—Dizziness—Prednisolone—atopic dermatitis	0.000362	0.000769	CcSEcCtD
Fulvestrant—Asthenia—Triamcinolone—atopic dermatitis	0.000362	0.000767	CcSEcCtD
Fulvestrant—Abdominal pain—Betamethasone—atopic dermatitis	0.000361	0.000767	CcSEcCtD
Fulvestrant—Abdominal pain—Dexamethasone—atopic dermatitis	0.000361	0.000767	CcSEcCtD
Fulvestrant—Body temperature increased—Dexamethasone—atopic dermatitis	0.000361	0.000767	CcSEcCtD
Fulvestrant—Body temperature increased—Betamethasone—atopic dermatitis	0.000361	0.000767	CcSEcCtD
Fulvestrant—Asthenia—Methylprednisolone—atopic dermatitis	0.000361	0.000765	CcSEcCtD
Fulvestrant—Insomnia—Prednisone—atopic dermatitis	0.00036	0.000764	CcSEcCtD
Fulvestrant—Paraesthesia—Prednisone—atopic dermatitis	0.000358	0.000758	CcSEcCtD
Fulvestrant—Pruritus—Triamcinolone—atopic dermatitis	0.000356	0.000756	CcSEcCtD
Fulvestrant—Pruritus—Methylprednisolone—atopic dermatitis	0.000356	0.000755	CcSEcCtD
Fulvestrant—Dizziness—Hydrocortisone—atopic dermatitis	0.000354	0.000751	CcSEcCtD
Fulvestrant—Dyspepsia—Prednisone—atopic dermatitis	0.00035	0.000744	CcSEcCtD
Fulvestrant—Decreased appetite—Prednisone—atopic dermatitis	0.000346	0.000734	CcSEcCtD
Fulvestrant—Rash—Prednisolone—atopic dermatitis	0.000345	0.000733	CcSEcCtD
Fulvestrant—Dermatitis—Prednisolone—atopic dermatitis	0.000345	0.000732	CcSEcCtD
Fulvestrant—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000344	0.00073	CcSEcCtD
Fulvestrant—Fatigue—Prednisone—atopic dermatitis	0.000343	0.000728	CcSEcCtD
Fulvestrant—Headache—Prednisolone—atopic dermatitis	0.000343	0.000728	CcSEcCtD
Fulvestrant—Constipation—Prednisone—atopic dermatitis	0.00034	0.000722	CcSEcCtD
Fulvestrant—Vomiting—Hydrocortisone—atopic dermatitis	0.00034	0.000722	CcSEcCtD
Fulvestrant—Rash—Hydrocortisone—atopic dermatitis	0.000337	0.000716	CcSEcCtD
Fulvestrant—Dermatitis—Hydrocortisone—atopic dermatitis	0.000337	0.000715	CcSEcCtD
Fulvestrant—Headache—Hydrocortisone—atopic dermatitis	0.000335	0.000711	CcSEcCtD
Fulvestrant—Dizziness—Triamcinolone—atopic dermatitis	0.000333	0.000707	CcSEcCtD
Fulvestrant—Dizziness—Methylprednisolone—atopic dermatitis	0.000332	0.000705	CcSEcCtD
Fulvestrant—Asthenia—Dexamethasone—atopic dermatitis	0.000328	0.000696	CcSEcCtD
Fulvestrant—Asthenia—Betamethasone—atopic dermatitis	0.000328	0.000696	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000326	0.000691	CcSEcCtD
Fulvestrant—Nausea—Prednisolone—atopic dermatitis	0.000325	0.00069	CcSEcCtD
Fulvestrant—Pruritus—Dexamethasone—atopic dermatitis	0.000323	0.000686	CcSEcCtD
Fulvestrant—Pruritus—Betamethasone—atopic dermatitis	0.000323	0.000686	CcSEcCtD
Fulvestrant—Vomiting—Triamcinolone—atopic dermatitis	0.00032	0.00068	CcSEcCtD
Fulvestrant—Vomiting—Methylprednisolone—atopic dermatitis	0.00032	0.000678	CcSEcCtD
Fulvestrant—Nausea—Hydrocortisone—atopic dermatitis	0.000318	0.000674	CcSEcCtD
Fulvestrant—Rash—Triamcinolone—atopic dermatitis	0.000318	0.000674	CcSEcCtD
Fulvestrant—Dermatitis—Triamcinolone—atopic dermatitis	0.000317	0.000673	CcSEcCtD
Fulvestrant—Rash—Methylprednisolone—atopic dermatitis	0.000317	0.000673	CcSEcCtD
Fulvestrant—Dermatitis—Methylprednisolone—atopic dermatitis	0.000317	0.000672	CcSEcCtD
Fulvestrant—Urticaria—Prednisone—atopic dermatitis	0.000316	0.000671	CcSEcCtD
Fulvestrant—Headache—Triamcinolone—atopic dermatitis	0.000316	0.00067	CcSEcCtD
Fulvestrant—Headache—Methylprednisolone—atopic dermatitis	0.000315	0.000668	CcSEcCtD
Fulvestrant—Body temperature increased—Prednisone—atopic dermatitis	0.000315	0.000668	CcSEcCtD
Fulvestrant—Abdominal pain—Prednisone—atopic dermatitis	0.000315	0.000668	CcSEcCtD
Fulvestrant—Diarrhoea—Dexamethasone—atopic dermatitis	0.000313	0.000664	CcSEcCtD
Fulvestrant—Diarrhoea—Betamethasone—atopic dermatitis	0.000313	0.000664	CcSEcCtD
Fulvestrant—Dizziness—Betamethasone—atopic dermatitis	0.000302	0.000641	CcSEcCtD
Fulvestrant—Dizziness—Dexamethasone—atopic dermatitis	0.000302	0.000641	CcSEcCtD
Fulvestrant—Nausea—Triamcinolone—atopic dermatitis	0.000299	0.000635	CcSEcCtD
Fulvestrant—Nausea—Methylprednisolone—atopic dermatitis	0.000299	0.000634	CcSEcCtD
Fulvestrant—Hypersensitivity—Prednisone—atopic dermatitis	0.000293	0.000622	CcSEcCtD
Fulvestrant—Vomiting—Betamethasone—atopic dermatitis	0.000291	0.000617	CcSEcCtD
Fulvestrant—Vomiting—Dexamethasone—atopic dermatitis	0.000291	0.000617	CcSEcCtD
Fulvestrant—Rash—Betamethasone—atopic dermatitis	0.000288	0.000612	CcSEcCtD
Fulvestrant—Rash—Dexamethasone—atopic dermatitis	0.000288	0.000612	CcSEcCtD
Fulvestrant—Dermatitis—Dexamethasone—atopic dermatitis	0.000288	0.000611	CcSEcCtD
Fulvestrant—Dermatitis—Betamethasone—atopic dermatitis	0.000288	0.000611	CcSEcCtD
Fulvestrant—Headache—Dexamethasone—atopic dermatitis	0.000286	0.000608	CcSEcCtD
Fulvestrant—Headache—Betamethasone—atopic dermatitis	0.000286	0.000608	CcSEcCtD
Fulvestrant—Asthenia—Prednisone—atopic dermatitis	0.000286	0.000606	CcSEcCtD
Fulvestrant—Pruritus—Prednisone—atopic dermatitis	0.000282	0.000598	CcSEcCtD
Fulvestrant—Diarrhoea—Prednisone—atopic dermatitis	0.000272	0.000578	CcSEcCtD
Fulvestrant—Nausea—Betamethasone—atopic dermatitis	0.000272	0.000576	CcSEcCtD
Fulvestrant—Nausea—Dexamethasone—atopic dermatitis	0.000272	0.000576	CcSEcCtD
Fulvestrant—Dizziness—Prednisone—atopic dermatitis	0.000263	0.000559	CcSEcCtD
Fulvestrant—Vomiting—Prednisone—atopic dermatitis	0.000253	0.000537	CcSEcCtD
Fulvestrant—Rash—Prednisone—atopic dermatitis	0.000251	0.000533	CcSEcCtD
Fulvestrant—Dermatitis—Prednisone—atopic dermatitis	0.000251	0.000532	CcSEcCtD
Fulvestrant—Headache—Prednisone—atopic dermatitis	0.000249	0.000529	CcSEcCtD
Fulvestrant—Nausea—Prednisone—atopic dermatitis	0.000236	0.000502	CcSEcCtD
Fulvestrant—ESRRA—Nuclear Receptors—PPARA—atopic dermatitis	0.000193	0.0455	CbGpPWpGaD
Fulvestrant—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000191	0.0451	CbGpPWpGaD
Fulvestrant—ESRRA—Transcriptional activation of mitochondrial biogenesis—PPARA—atopic dermatitis	0.000168	0.0398	CbGpPWpGaD
Fulvestrant—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000154	0.0364	CbGpPWpGaD
Fulvestrant—ESRRA—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000152	0.036	CbGpPWpGaD
Fulvestrant—ESR1—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000146	0.0345	CbGpPWpGaD
Fulvestrant—ESRRA—Mitochondrial biogenesis—PPARA—atopic dermatitis	0.000145	0.0344	CbGpPWpGaD
Fulvestrant—ESR2—Nuclear Receptors—PPARA—atopic dermatitis	0.000123	0.029	CbGpPWpGaD
Fulvestrant—NR1H4—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000111	0.0263	CbGpPWpGaD
Fulvestrant—ESR2—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	9.69e-05	0.0229	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—SELE—atopic dermatitis	9.05e-05	0.0214	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	8.64e-05	0.0204	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.52e-05	0.0201	CbGpPWpGaD
Fulvestrant—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	8.37e-05	0.0198	CbGpPWpGaD
Fulvestrant—ESRRA—PPARA activates gene expression—PPARA—atopic dermatitis	8.23e-05	0.0195	CbGpPWpGaD
Fulvestrant—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	8.06e-05	0.019	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL13—atopic dermatitis	7.3e-05	0.0173	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.81e-05	0.0161	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	6.72e-05	0.0159	CbGpPWpGaD
Fulvestrant—ESRRA—Organelle biogenesis and maintenance—PPARA—atopic dermatitis	6.6e-05	0.0156	CbGpPWpGaD
Fulvestrant—NR1H4—Orphan transporters—PPARA—atopic dermatitis	6.29e-05	0.0149	CbGpPWpGaD
Fulvestrant—ESR1—Nuclear Receptors—PPARA—atopic dermatitis	6.18e-05	0.0146	CbGpPWpGaD
Fulvestrant—NR1H4—PPARA activates gene expression—PPARA—atopic dermatitis	6.02e-05	0.0142	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL5—atopic dermatitis	5.98e-05	0.0141	CbGpPWpGaD
Fulvestrant—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	5.89e-05	0.0139	CbGpPWpGaD
Fulvestrant—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	5.55e-05	0.0131	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—IL5—atopic dermatitis	5.32e-05	0.0126	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.98e-05	0.0118	CbGpPWpGaD
Fulvestrant—ESR1—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	4.89e-05	0.0115	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	4.79e-05	0.0113	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL10—atopic dermatitis	4.57e-05	0.0108	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL10—atopic dermatitis	4.37e-05	0.0103	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL4—atopic dermatitis	4.25e-05	0.0101	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—NGF—atopic dermatitis	4.25e-05	0.01	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.07e-05	0.00962	CbGpPWpGaD
Fulvestrant—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	4.06e-05	0.00959	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—atopic dermatitis	3.89e-05	0.0092	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GLB1—atopic dermatitis	3.79e-05	0.00897	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ADSL—atopic dermatitis	3.64e-05	0.0086	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.17e-05	0.00749	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GLB1—atopic dermatitis	3.03e-05	0.00717	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.98e-05	0.00704	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IFNG—atopic dermatitis	2.95e-05	0.00697	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ADSL—atopic dermatitis	2.91e-05	0.00687	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.77e-05	0.00654	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—CXCL8—atopic dermatitis	2.74e-05	0.00648	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.69e-05	0.00635	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—IFNG—atopic dermatitis	2.63e-05	0.00622	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—PPARA—atopic dermatitis	2.63e-05	0.00622	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IFNG—atopic dermatitis	2.57e-05	0.00608	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	2.5e-05	0.0059	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—MAPK8—atopic dermatitis	2.41e-05	0.0057	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	2.4e-05	0.00566	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CXCL8—atopic dermatitis	2.39e-05	0.00565	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—IL2—atopic dermatitis	2.34e-05	0.00553	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	2.33e-05	0.00551	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL2—atopic dermatitis	2.29e-05	0.0054	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GLB1—atopic dermatitis	2.22e-05	0.00524	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.21e-05	0.00523	CbGpPWpGaD
Fulvestrant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.2e-05	0.00521	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—IL1B—atopic dermatitis	2.17e-05	0.00513	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ADSL—atopic dermatitis	2.13e-05	0.00502	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	2.05e-05	0.00485	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—MAPK8—atopic dermatitis	1.99e-05	0.00471	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—PPARA—atopic dermatitis	1.92e-05	0.00454	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.87e-05	0.00442	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	1.74e-05	0.00411	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—PPARA—atopic dermatitis	1.67e-05	0.00396	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	1.64e-05	0.00387	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.62e-05	0.00382	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—atopic dermatitis	1.54e-05	0.00364	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.54e-05	0.00363	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	1.5e-05	0.00355	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.48e-05	0.0035	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.4e-05	0.00332	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	1.36e-05	0.0032	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—atopic dermatitis	1.34e-05	0.00318	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—PPARA—atopic dermatitis	1.27e-05	0.00299	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PPARA—atopic dermatitis	1.23e-05	0.00291	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FCER2—atopic dermatitis	1.03e-05	0.00243	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARA—atopic dermatitis	9.85e-06	0.00233	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL22—atopic dermatitis	9.57e-06	0.00226	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	9.42e-06	0.00223	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARA—atopic dermatitis	9.25e-06	0.00219	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL27—atopic dermatitis	8.53e-06	0.00202	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARA—atopic dermatitis	8.44e-06	0.00199	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARA—atopic dermatitis	8.06e-06	0.0019	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL17—atopic dermatitis	7.65e-06	0.00181	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	7.46e-06	0.00176	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—atopic dermatitis	7.22e-06	0.00171	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARA—atopic dermatitis	7.19e-06	0.0017	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KIF3A—atopic dermatitis	6.82e-06	0.00161	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL11—atopic dermatitis	6.17e-06	0.00146	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CMA1—atopic dermatitis	6.17e-06	0.00146	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT6—atopic dermatitis	5.8e-06	0.00137	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR3—atopic dermatitis	5.03e-06	0.00119	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPS—atopic dermatitis	4.48e-06	0.00106	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TAC1—atopic dermatitis	4.48e-06	0.00106	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCR3—atopic dermatitis	4.4e-06	0.00104	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL5—atopic dermatitis	4.17e-06	0.000985	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARA—atopic dermatitis	4.06e-06	0.00096	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL10—atopic dermatitis	3.55e-06	0.00084	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.17e-06	0.00075	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL5—atopic dermatitis	3.06e-06	0.000723	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.04e-06	0.000719	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NGF—atopic dermatitis	2.83e-06	0.000669	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR5—atopic dermatitis	2.76e-06	0.000651	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NFKBIA—atopic dermatitis	2.34e-06	0.000552	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL8—atopic dermatitis	1.67e-06	0.000394	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2—atopic dermatitis	1.59e-06	0.000376	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK8—atopic dermatitis	1.47e-06	0.000346	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.03e-06	0.000243	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—atopic dermatitis	9.36e-07	0.000221	CbGpPWpGaD
